| Product Code: ETC417024 | Publication Date: Oct 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Indonesia Buprenorphine Market is projected to witness mixed growth rate patterns during 2025 to 2029. Starting at 8.83% in 2025, the market peaks at 10.08% in 2027, and settles at 9.91% by 2029.

The Buprenorphine market in Indonesia is projected to grow at a high growth rate of 10.08% by 2027, within the Asia region led by China, along with other countries like India, Japan, Australia and South Korea, collectively shaping a dynamic and evolving market environment driven by innovation and increasing adoption of emerging technologies.

Buprenorphine, primarily used in opioid addiction treatment, is witnessing a growing demand due to the increasing awareness of substance abuse issues. The market outlook is influenced by government initiatives to combat addiction and improve healthcare access. Market participants should stay informed about regulatory changes and collaborate with healthcare providers.
The Buprenorphine market in Indonesia is poised for substantial expansion due to various factors. One of the primary drivers is the increasing awareness of Buprenorphine`s role in opioid addiction treatment. The opioid addiction epidemic is a growing concern in Indonesia, and Buprenorphine is recognized as a key medication for harm reduction and addiction recovery. Furthermore, government initiatives and policies aimed at addressing substance abuse issues are likely to support the market`s growth. Additionally, the expanding healthcare infrastructure, coupled with rising healthcare expenditure, is expected to increase the accessibility of Buprenorphine. However, regulatory compliance and the need for stringent monitoring to prevent misuse are challenges that need to be managed in this market.
The Buprenorphine market in Indonesia might encounter challenges related to its use in addiction treatment programs. These challenges may include stigma associated with addiction, limited access to treatment centers, and the need for comprehensive addiction management programs.
The buprenorphine market, primarily used for opioid addiction treatment, faced challenges during the pandemic. The lockdowns and restrictions affected access to addiction treatment centers, leading to concerns about patients` well-being. Telehealth services emerged as a crucial tool in providing continuity of care.
The Indonesia Buprenorphine market is witnessing substantial growth due to rising awareness of opioid addiction treatment. Key players like PT Indofarma Tbk and PT Tembikar Sarana Persada are actively contributing to the production and distribution of Buprenorphine-based medications. The market is poised for continued expansion as addiction treatment programs gain momentum across the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Buprenorphine Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Buprenorphine Market - Industry Life Cycle |
3.4 Indonesia Buprenorphine Market - Porter's Five Forces |
3.5 Indonesia Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Indonesia Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Indonesia Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Indonesia Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of buprenorphine in managing opioid addiction |
4.2.2 Growing government initiatives to address the opioid crisis in Indonesia |
4.2.3 Rise in the number of healthcare facilities offering buprenorphine treatment |
4.3 Market Restraints |
4.3.1 Stringent regulations and restrictions on the usage of buprenorphine |
4.3.2 Limited availability of skilled healthcare professionals trained in buprenorphine treatment |
5 Indonesia Buprenorphine Market Trends |
6 Indonesia Buprenorphine Market, By Types |
6.1 Indonesia Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Buprenorphine Market Revenues & Volume, By Application, 2021-2031F |
6.1.3 Indonesia Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.4 Indonesia Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 Indonesia Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 Indonesia Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 Indonesia Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 Indonesia Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Indonesia Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Indonesia Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Indonesia Buprenorphine Market Import-Export Trade Statistics |
7.1 Indonesia Buprenorphine Market Export to Major Countries |
7.2 Indonesia Buprenorphine Market Imports from Major Countries |
8 Indonesia Buprenorphine Market Key Performance Indicators |
8.1 Number of patients enrolled in buprenorphine treatment programs |
8.2 Percentage increase in the number of healthcare facilities providing buprenorphine treatment |
8.3 Rate of successful outcomes and patient satisfaction with buprenorphine therapy |
8.4 Average wait time for patients seeking buprenorphine treatment |
8.5 Number of educational campaigns and events promoting buprenorphine awareness and its benefits |
9 Indonesia Buprenorphine Market - Opportunity Assessment |
9.1 Indonesia Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Indonesia Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Indonesia Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Indonesia Buprenorphine Market - Competitive Landscape |
10.1 Indonesia Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |